ELANCO ANIMAL HEALTH INC (ELAN) Stock Income Statement
NYSE:ELAN - New York Stock Exchange, Inc. - US28414H1032 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.44B | 4.42B | 4.41B | 4.76B | 3.27B | |||
| Cost Of Goods | 2.00B | 1.93B | 1.91B | 2.13B | 1.67B | |||
| Gross Profit | 2.44B | 2.49B | 2.50B | 2.63B | 1.60B | |||
| Operating Expenses | 2.19B | 2.16B | 2.11B | 2.33B | 1.69B | |||
| Research and Development | 344.00M | 327.00M | 321.00M | 369.00M | 329.00M | |||
| Selling, General, and Administrative Expenses | 1.31B | 1.28B | 1.26B | 1.40B | 997.00M | |||
| Operating Income | 251.00M | 326.00M | 384.00M | 304.00M | -82.00M | |||
| Interest Income/Expense | -235.00M | -277.00M | -241.00M | -236.00M | -150.00M | |||
| Other Income/Expense | -18.00M | -75.00M | -32.00M | -5.00M | 178.00M | |||
| Non Recurring Items | 490.00M | -1.17B | -183.00M | -634.00M | -627.00M | |||
| Income Before Taxes | 488.00M | -1.20B | -72.00M | -571.00M | -677.00M | |||
| Income Tax | 150.00M | 36.00M | 6.00M | -88.00M | -103.00M | |||
| Net Income | 338.00M | -1.23B | -78.00M | -483.00M | -574.00M | |||
| EBITDA | 913.00M | 1.02B | 1.07B | 1.02B | 434.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.68 | -2.50 | -0.16 | -0.99 | -1.30 | |||
| Non GAAP EPS | 0.91 | 0.89 | 1.11 | 1.05 | 0.47 | |||
| Statistics | ||||||||
| Gross Profit Margin | 54.88% | 56.28% | 56.63% | 55.25% | 49.04% | |||
| Profit Margin | 7.61% | -27.87% | -1.77% | -10.14% | -17.55% | |||
| Operating Profit Margin | 5.65% | 7.38% | 8.71% | 6.38% | -2.51% | |||
All data in USD